Tecfidera Excels at Reducing RRMS Relapse Rate & Managing the Bad Days with MS

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with Tecfidera led to fewer relapses in relapsing-remitting multiple sclerosis patients than Aubagio or injectable immunomodulators.Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “It’s Just One of Those MS ‘Snow Days’.”=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/